RE:Pareto on June 6 posting got it correct! Looking back in the rear mirror there is an ocean of room for complaints, trust me - I've been there.
But - if you truly are a shareholder and care about the value of your investment - now it's a good time to contribute to a positive sentiment.
- We have first class science on board and a well documented stellar anti-aging clinical trial.
- The management have engaged a professional third party to make sure that the true value will be unleashed for the benefit of shareholders.
- The company has met with parties before and during the conference and will follow up with more meetings with the few not attending. Basicallly, industry coverage is great.
I would head for multiple deals based on the fact that when the first party sign a deal - everyone must follow and try to distinguish on formulation. Please realize that the compound is a 'must-have', sort of the next generation where everyone forgets about the previous one.
Such a superior product should generate double-digit royalty. Do some basic calculation and focus on the future instead of historical mistakes. Spread the word and look forward to a healthy ROI.